Lupin Of India, Forest Of U.S. Allies To Market Medical Devices In U.S.
This article was originally published in PharmAsia News
India's Lupin Laboratories and Forest Laboratories of the U.S. have agreed to share promotion and marketing of one of Lupin's medical devices in the United States. Forest's 50-person sales force is to be tapped to promote Lupin's Aerochamber products, such as AerochamberPlus, a valved holding chamber device with metered dose inhalers, to pediatricians. Lupin seeks to expand its presence in the U.S. respiratory market. (Click here for more
You may also be interested in...
Despite leading multinational pharma firms including AstraZeneca again delivering double-digit growth in China, the impact of coronavirus and an expanding volume-based purchasing scheme begin to surface.
The study is designed to support the regulatory approval process in China and confirm that the safety and immunogenicity profile observed in German and US trials is comparable to that of Chinese participants, according to BioNTech.
The UK Department of Health and Social Care recently asked medical device and pharmaceutical companies to establish contingency measures in case of supply problems post-Brexit.